These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 158022)

  • 1. On the mechanism of the reaction between human alpha 2-antiplasmin and plasmin.
    Wiman B; Collen D
    J Biol Chem; 1979 Sep; 254(18):9291-7. PubMed ID: 158022
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
    Rouy D; Anglés-Cano E
    Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmin inhibitors in the prevention of systemic effects during thrombolytic therapy: specific role of the plasminogen-binding form of alpha 2-antiplasmin.
    Leebeek FW; Kluft C; Knot EA; Los P; Cohen AF; Six AJ
    J Am Coll Cardiol; 1990 May; 15(6):1212-20. PubMed ID: 1691750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monoclonal antibody specific for Lys-plasminogen. Application to the study of the activation pathways of plasminogen in vivo.
    Holvoet P; Lijnen HR; Collen D
    J Biol Chem; 1985 Oct; 260(22):12106-11. PubMed ID: 2413020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of catalytic activity of plasminogen by monoclonal antibody IV-Ic in the presence of divalent metal cations and alpha2-antiplasmin.
    Sokolovskaya LI; Slominskii AY; Volkov GL
    Biochemistry (Mosc); 2006 Jun; 71(6):627-33. PubMed ID: 16827654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
    Nilsson T; Sjöholm I; Wiman B
    Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the conformational changes of plasminogen induced during activation to plasmin and by 6-aminohexanoic acid.
    Sjöholm I
    Eur J Biochem; 1973 Nov; 39(2):471-9. PubMed ID: 4272770
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
    Ries M; Klinge J; Rauch R; Keuper H; Harms D
    Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of human plasminogen by equimolar levels of streptokinase.
    Bajaj AP; Castellino FJ
    J Biol Chem; 1977 Jan; 252(2):492-8. PubMed ID: 137901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
    Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
    J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of three different molecular forms of the alpha 2 plasmin inhibitor.
    Clemmensen I; Thorsen S; Müllertz S; Petersen LC
    Eur J Biochem; 1981 Nov; 120(1):105-12. PubMed ID: 6458494
    [No Abstract]   [Full Text] [Related]  

  • 15. Sulfation of a tyrosine residue in the plasmin-binding domain of alpha 2-antiplasmin.
    Hortin G; Fok KF; Toren PC; Strauss AW
    J Biol Chem; 1987 Mar; 262(7):3082-5. PubMed ID: 2434496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
    Walther PJ; Steinman HM; Hill RL; McKee PA
    J Biol Chem; 1974 Feb; 249(4):1173-81. PubMed ID: 4273519
    [No Abstract]   [Full Text] [Related]  

  • 17. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
    Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stopped-flow fluorescence kinetics of bovine alpha 2-antiplasmin inhibition of bovine midiplasmin.
    Christensen S; Sottrup-Jensen L; Christensen U
    Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):97-102. PubMed ID: 7529997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin.
    Ries M; Easton RL; Longstaff C; Zenker M; Morris HR; Dell A; Gaffney PJ
    Thromb Res; 2002 Feb; 105(3):247-56. PubMed ID: 11927131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
    Schneider M; Brufatto N; Neill E; Nesheim M
    J Biol Chem; 2004 Apr; 279(14):13340-5. PubMed ID: 14715654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.